PERISYL COMBI (Alphapharm Pty Ltd)
Product name
PERISYL COMBI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
106 (255 working days)
Active ingredients
indapamide hemihydrate; perindopril erbumine
Registration type
New generic medicine
Indication
PERISYL COMBI 4/1.25 (tablet) is indicated for:
- Treatment of hypertension. Treatment should not be initiated with this combination.
PERISYL COMBI 2/0.625 (tablet) is indicated for:
- Treatment of hypertension.